13th Apr 2005 16:49
GlaxoSmithKline PLC13 April 2005 Director's Interests I give below details of changes in interests in the Ordinary Shares and AmericanDepositary Receipts (ADRs) of GlaxoSmithKline plc in respect of theunder-mentioned directors:- Dr J P Garnier The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and Dr Garnier on 13 April 2005 that his interest had notionally increased by 3819.757 ADRs at a price of $47.43 per ADR following the notional re-investment of the dividend paid to shareholders on 07 April 2005. Dr T Yamada The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and Dr Yamada on 13 April 2005 that his interest had notionally increased by 1145.928 ADRs at a price of $47.43 per ADR following the notional re-investment of the dividend paid to shareholders on 07 April 2005. Mr J S Heslop The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and Mr Heslop on 13 April 2005 that his interest had notionally increased by 148.919 Ordinary Shares at a price of £12.49 per Ordinary Share following the notional re-investment of the dividend paid to shareholders on 07 April 2005. The notional dividends accrued will be paid out in proportion to the percentageof participants' Performance Share Plan holdings that vest following the end ofthe relevant three year measurement period. S M BicknellCompany Secretary 13 April 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline